India to United States: Docetaxel Export Trade Route
India has recorded 111 verified shipments of Docetaxel exported to United States, representing a combined trade value of $9.2M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $82.6K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 66% of total export value with 57 shipments worth $6.0M USD. On the buying side, MYLAN INSTITUTIONAL INC 2898 is the largest importer in United States with $5.7M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Docetaxel corridor is one of India's established pharmaceutical export routes, with 111 shipments documented worth a combined $9.2M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $82.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 17.2%, placing it at rank #19 among India's top docetaxel export destinations globally.
On the import side, key buyers of Indian docetaxel in United States include MYLAN INSTITUTIONAL INC 2898, PFIZER SERVICE COMPANY BV, J. KNIPPER & COMPANY and 20 others. MYLAN INSTITUTIONAL INC 2898 is the single largest importer with 53 shipments valued at $5.7M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#19
- Annual growth+17.2%
- Demand growth+16.7%
- Regulatory ease85/100
Top 10 Indian Docetaxel Exporters to United States
Showing top 10 of 14 Indian suppliers exporting Docetaxel to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $105.6K per shipment | 57 | $6.0M | 65.7% |
| 2 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED Avg $192.8K per shipment | 9 | $1.7M | 18.9% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED Avg $102.2K per shipment | 11 | $1.1M | 12.3% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $169.4K per shipment | 1 | $169.4K | 1.8% |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED Avg $51.4K per shipment | 2 | $102.8K | 1.1% |
| 6 | ATLAS ENTERPRISES Avg $478 per shipment | 10 | $4.8K | 0.1% |
| 7 | DELON INC. Avg $1.5K per shipment | 3 | $4.4K | 0.0% |
| 8 | VINAYAK ASSOCIATES Avg $932 per shipment | 2 | $1.9K | 0.0% |
| 9 | KOIT BIOPHARMA PRIVATE LIMITED Avg $567 per shipment | 2 | $1.1K | 0.0% |
| 10 | VEA IMPEX (I) PRIVATE LIMITED Avg $179 per shipment | 6 | $1.1K | 0.0% |
This table shows the top 10 of 14 Indian companies exporting docetaxel to United States, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ATLAS ENTERPRISES, DELON INC., VINAYAK ASSOCIATES, KOIT BIOPHARMA PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 57 shipments worth $6.0M USD, giving it a 66% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to United States Docetaxel export route.
Top 10 Docetaxel Importers in United States
Showing top 10 of 23 known buyers in United States receiving Docetaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian docetaxel in United States include MYLAN INSTITUTIONAL INC 2898, PFIZER SERVICE COMPANY BV, J. KNIPPER & COMPANY, XXIZEXXSERXXCE XXMPAXX BV, MYLAN INSTITUTIONAL INC, among 23 total buyers. The largest importer is MYLAN INSTITUTIONAL INC 2898, accounting for $5.7M USD across 53 shipments — representing 63% of all docetaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC 2898 | 53 | $5.7M | 62.7% |
| 2 | PFIZER SERVICE COMPANY BV | 7 | $1.2M | 12.8% |
| 3 | J. KNIPPER & COMPANY | 9 | $982.1K | 10.7% |
| 4 | XXIZEXXSERXXCE XXMPAXX BV | 2 | $565.6K | 6.2% |
| 5 | MYLAN INSTITUTIONAL INC | 4 | $276.5K | 3.0% |
| 6 | EVERSANA LIFE SCIENCES SERVICES,LLC | 1 | $169.4K | 1.8% |
| 7 | J KNIPPER COMPANY | 2 | $141.7K | 1.5% |
| 8 | EUGIA US LLC, | 2 | $102.8K | 1.1% |
| 9 | COMERCIALIZADORA MEDENOR SA DE CV | 4 | $5.1K | 0.1% |
| 10 | VERONICA HERNANDEZ | 4 | $1.7K | 0.0% |
Showing top 10 of 23 Docetaxel importers in United States on this route.
Top 10 Docetaxel Formulations Imported by United States
Showing top 10 of 90 product formulations shipped on the India to United States Docetaxel route, ranked by trade value
United States imports a wide range of docetaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DOCETAXEL INJ.160MG-USPREMIER-F000052363 — accounts for $812.1K USD across 3 shipments. There are 90 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DOCETAXEL INJ.160MG-USPREMIER-F000052363 | 3 | $812.1K | 8.9% |
| 2 | DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL US | 3 | $509.6K | 5.6% |
| 3 | DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL US | 3 | $505.5K | 5.5% |
| 4 | DOCETAXEL INJ USP 160MG/16 ML AP US | 2 | $356.4K | 3.9% |
| 5 | DOCETAXEL INJ USP 10MG 8ML 1S MYL US (78 | 3 | $317.8K | 3.5% |
| 6 | DOCETAXEL INJ 160MG/8ML-1S-MYLAN US-MDV | 4 | $276.5K | 3.0% |
| 7 | DOCETAXEL INJ.20MG-USPREMIER-F000052191 | 1 | $236.9K | 2.6% |
| 8 | DOCETAXEL INJ. 80MG US -F000206934 | 1 | $208.0K | 2.3% |
| 9 | DOCETAXEL INJECTION USP(10MG/ML)16ML 1SMYLAN US (3234835) TAX VAL 17131579.83 | 1 | $199.1K | 2.2% |
| 10 | DOCETAXEL INJ USP 160MG/ 16ML AP US | 1 | $196.5K | 2.1% |
Showing top 10 of 90 Docetaxel formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 19 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's docetaxel exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 57 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $82.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as docetaxel inj usp 10mg/ml 16ml 1s myl us and docetaxel inj usp 10mg/ml 16ml 1s myl us , suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN INSTITUTIONAL INC 2898 is the largest importer with 53 shipments worth $5.7M USD — representing 63% of all docetaxel imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $9.2M
- Avg. Shipment
- $82.6K
- Suppliers
- 14
- Buyers
- 23
- Transit (Sea)
- ~22 days
- Annual Growth
- +17.2%
Reverse Direction
United States → India — Docetaxel (Import)Other Docetaxel Routes
Unlock the Full India to United States Docetaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 111 shipments on this route.
Frequently Asked Questions — India to United States Docetaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Docetaxel to United States?
The leading Indian exporters of Docetaxel to United States are MYLAN LABORATORIES LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 66% of total trade value on this route.
Q What is the total value of Docetaxel exports from India to United States?
India exports Docetaxel to United States worth approximately $9.2M USD across 111 recorded shipments. The average value per shipment is $82.6K USD.
Q Which ports does India use to ship Docetaxel to United States?
The most active port of origin is SAHAR AIR with 19 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United States for Docetaxel?
The average transit time for Docetaxel shipments from India to United States is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Docetaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.2% with demand growth tracking at 16.7%. The route is ranked #19 among India's top Docetaxel export destinations globally.
Q How many suppliers are active on the India to United States Docetaxel route?
There are currently 14 active Indian suppliers exporting Docetaxel to United States. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 66% of total shipment value.
Q Who are the main importers of Docetaxel from India in United States?
The leading importers of Indian Docetaxel in United States include MYLAN INSTITUTIONAL INC 2898, PFIZER SERVICE COMPANY BV, J. KNIPPER & COMPANY, XXIZEXXSERXXCE XXMPAXX BV, MYLAN INSTITUTIONAL INC. MYLAN INSTITUTIONAL INC 2898 is the largest buyer with 53 shipments worth $5.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Docetaxel.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 23 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 111 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
111 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists